Cedar Mountain Advisors’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.1K | Buy |
911
+12
| +1% | +$291 | ﹤0.01% | 154 |
|
|
2025
Q1 | $22.8K | Buy |
899
+12
| +1% | +$304 | 0.01% | 145 |
|
|
2024
Q4 | $23.5K | Buy |
887
+24
| +3% | +$637 | 0.01% | 144 |
|
|
2024
Q3 | $25K | Buy |
863
+10
| +1% | +$289 | 0.01% | 136 |
|
|
2024
Q2 | $23.9K | Buy |
853
+11
| +1% | +$308 | 0.01% | 125 |
|
|
2024
Q1 | $23.4K | Buy |
842
+11
| +1% | +$305 | 0.01% | 126 |
|
|
2023
Q4 | $23.9K | Buy |
831
+9
| +1% | +$259 | 0.01% | 118 |
|
|
2023
Q3 | $27.3K | Buy |
822
+8
| +1% | +$265 | 0.01% | 95 |
|
|
2023
Q2 | $29.9K | Buy |
814
+7
| +0.9% | +$257 | 0.01% | 98 |
|
|
2023
Q1 | $32.9K | Buy |
807
+6
| +0.7% | +$245 | 0.01% | 91 |
|
|
2022
Q4 | $41K | Buy |
801
+5
| +0.6% | +$256 | 0.01% | 82 |
|
|
2022
Q3 | $35K | Buy |
796
+6
| +0.8% | +$264 | 0.01% | 83 |
|
|
2022
Q2 | $41K | Buy |
790
+5
| +0.6% | +$259 | 0.01% | 81 |
|
|
2022
Q1 | $41K | Buy |
785
+5
| +0.6% | +$261 | 0.01% | 88 |
|
|
2021
Q4 | $46K | Buy |
780
+5
| +0.6% | +$295 | 0.01% | 77 |
|
|
2021
Q3 | $33K | Sell |
775
-67
| -8% | -$2.85K | 0.01% | 91 |
|
|
2021
Q2 | $33K | Hold |
842
| – | – | 0.01% | 93 |
|
|
2021
Q1 | $31K | Hold |
842
| – | – | 0.01% | 97 |
|
|
2020
Q4 | $31K | Buy |
842
+271
| +47% | +$9.98K | 0.01% | 99 |
|
|
2020
Q3 | $20K | Hold |
571
| – | – | 0.01% | 106 |
|
|
2020
Q2 | $18K | Hold |
571
| – | – | 0.01% | 110 |
|
|
2020
Q1 | $18K | Hold |
571
| – | – | 0.01% | 93 |
|
|
2019
Q4 | $21K | Buy |
+571
| New | +$21K | 0.01% | 102 |
|